Orphanet together with the European Bioinformatics Institute jointly developed the Orphanet Rare Disease Ontology (ORDO) capturing the relationships between rare diseases, genes and other related information. ORDO also contains links to other biomedical ontologies, databases, and classification systems.

The Orphan Drug Act defines a rare disease as a disease or condition that affects less than 200,000 people in the United States.